Wu CH - Search Results

1

[The difference of IL-28B polymorphisms between hepatitis C patients with and without cryoglobulinemia].

Fan XH, Wu CH, Zheng YY, Wang LF, Huo N, Shao CP, Lu HY, Xu XY, Wei L. Fan XH, et al. Among authors: wu ch. Zhonghua Gan Zang Bing Za Zhi. 2013 Jun;21(6):429-33. doi: 10.3760/cma.j.issn.1007-3418.2013.06.011. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24034843 Chinese.

2

[Study of the mechanism underlying the effect of SOCS3 rs4969170 A/G polymorphism on the occurrence of insulin resistance in chronic hepatitis C patients].

Li F, Zheng Y, Shao C, Fan X, Wang L, Huo N, Lu H, Wu C, Xu X. Li F, et al. Zhonghua Gan Zang Bing Za Zhi. 2015 Mar;23(3):171-4. doi: 10.3760/cma.j.issn.1007-3418.2015.03.003. Zhonghua Gan Zang Bing Za Zhi. 2015. PMID: 25938827 Chinese.

3

[Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].

Wu CH, Xu XY, Tian GS, Yu YY. Wu CH, et al. Zhonghua Yi Xue Za Zhi. 2006 Feb 14;86(6):390-3. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16677548 Chinese.

4

[An analysis of the pathohistology of liver tissues, clinical features and prognostic factors of chronic hepatitis B virus carriers].

Wu CH, Si CW, Tian GS, Yu YY, Xu XY, Wang TL. Wu CH, et al. Zhonghua Gan Zang Bing Za Zhi. 2007 Aug;15(8):577-81. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17711625 Chinese.

5

[An analysis of clinical characteristics and risk factors of cirrhosis-related hepatocellular carcinomas in patients with hepatitis C virus infection].

Wu CH, Tian GS, Xu XY, Yu YY, Huang T. Wu CH, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 Mar;16(3):210-4. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18364082 Chinese.

6

[High dose of pegylated interferon alpha-2a for the treatment of genotype1 chronic hepatitis C: a case report].

Wu CH, Wang LF, Xu XY. Wu CH, et al. Zhonghua Gan Zang Bing Za Zhi. 2010 Nov;18(11):873. doi: 10.3760/cma.j.issn.1007-3418.2010.11.025. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 21138646 Chinese. No abstract available.

7

Prevalence of abnormal glycometabolism in patients with chronic hepatitis C and related risk factors in China.

Wang LF, Wu CH, Shan Y, Fan XH, Huo N, Lu HY, Xu XY. Wang LF, et al. Among authors: wu ch. Chin Med J (Engl). 2011 Jan;124(2):183-8. Chin Med J (Engl). 2011. PMID: 21362362

8

[The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].

Fan XH, Wang LF, Liu LC, Yao Y, Shan Y, Lu HY, Wu CH, Xu XY, Wei L. Fan XH, et al. Among authors: wu ch. Zhonghua Gan Zang Bing Za Zhi. 2011 Oct;19(10):721-5. doi: 10.3760/cma.j.issn.1007-3418.2011.10.001. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22409840 Chinese.

9

Efficacy of pegylated interferon-alpha-2a plus ribavirin for patients aged at least 60 years with chronic hepatitis C.

Zheng YY, Fan XH, Wang LF, Tian D, Huo N, Lu HY, Wu CH, Xu XY, Wei L. Zheng YY, et al. Among authors: wu ch. Chin Med J (Engl). 2012 Jun;125(11):1852-6. Chin Med J (Engl). 2012. PMID: 22884041

10

Cryoglobulinemia is an independent factor negatively associated with sustained virological response in chronic hepatitis C patients.

Fan XH, Wu CH, Wang LF, Zheng YY, Yao Y, Lu HY, Xu XY, Wei L. Fan XH, et al. Among authors: wu ch. Chin Med J (Engl). 2012 Nov;125(22):4014-7. Chin Med J (Engl). 2012. PMID: 23158135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,003 results

Search Page

Filters